- Author
- Emiel De Jaeghere (UGent)
- Promoter
- Hannelore Denys (UGent) , Olivier De Wever (UGent) and Frédéric Amant
- Organization
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 36.80 MB
-
De Jaeghere omslag.pdf
- supplementary material
- |
- open access
- |
- |
- 4.65 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01JH6DVP5T9YZ42QQ475HQD1F9
- MLA
- De Jaeghere, Emiel. Immune Checkpoint Inhibitors in Gynecologic Cancer : Getting to Prime T(I)ME? Ghent University. Faculty of Medicine and Health Sciences, 2025.
- APA
- De Jaeghere, E. (2025). Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME? Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
- Chicago author-date
- De Jaeghere, Emiel. 2025. “Immune Checkpoint Inhibitors in Gynecologic Cancer : Getting to Prime T(I)ME?” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Chicago author-date (all authors)
- De Jaeghere, Emiel. 2025. “Immune Checkpoint Inhibitors in Gynecologic Cancer : Getting to Prime T(I)ME?” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Vancouver
- 1.De Jaeghere E. Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME? [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2025.
- IEEE
- [1]E. De Jaeghere, “Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME?,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2025.
@phdthesis{01JH6DVP5T9YZ42QQ475HQD1F9,
author = {{De Jaeghere, Emiel}},
isbn = {{9789465068039}},
language = {{eng}},
pages = {{297}},
publisher = {{Ghent University. Faculty of Medicine and Health Sciences}},
school = {{Ghent University}},
title = {{Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME?}},
year = {{2025}},
}